San José, Costa Rica, 18th December 2025. Microtechnologies, a global company specializing in advanced manufacturing for
medical devices, is marking 25 years of operations in Costa Rica, a period defined not only by sustained growth, but by a steady evolution toward more technically complex processes and industrial innovation developed locally.
What began as an early bet on Costa Rican talent has become an operation that today integrates flexible automation, modular robotics, and proprietary engineering solutions to meet the demanding standards of the global medical industry. This evolution has enabled the company to respond more agilely to market changes and scale capabilities from Costa Rica to other markets.
“Costa Rica has been key to our evolution as a company. We don’t just manufacture here; we develop processes, integrate technology, and build solutions that are now part of our global value proposition,” said Michael Tucci, CEO of Microtechnologies.
“Local talent has demonstrated an outstanding ability to adapt, innovate, and operate under the highest quality standards.”Today, Microtechnologies’ Costa Rica operation employs more than 560 people, operates nearly 9,000 square meters of specialized facilities, and holds international certifications that support its role within the global medical device value chain. Beyond its scale, the strategic value of the site lies in its ability to absorb technical complexity and translate it into efficient, traceable processes.
From an operational standpoint, the company has made a strategic decision to
develop
automation and smart manufacturing solutions in-house—an approach that has strengthened its resilience and responsiveness in an increasingly demanding global environment.
“The innovation we are developing today in Costa Rica is no coincidence. It is the result of investing in people, processes, and a culture of continuous improvement that allows us to evolve alongside our customers,” explained Carlos Mora, Country Manager of Microtechnologies in Costa Rica, referring to the strategic role the local operation has assumed within the group.
For
CINDE, Microtechnologies’ trajectory reflects a broader transformation of Costa Rica’s life sciences sector.
“Cases like this confirm that Costa Rica has moved into a different stage of its value proposition. Today, the country not only hosts operations, but develops local capabilities to innovate, automate, and solve complex challenges from within its territory,” said Marianela Urgellés, Managing Director of CINDE.
“This level of sophistication strengthens the sector’s resilience and positions Costa Rica as a trusted partner within critical global value chains.”With an operation that today delivers
advanced manufacturing solutions and innovation-driven processes for the global medical industry, Microtechnologies looks to the future from Costa Rica, building an increasingly integrated, flexible, and sophisticated platform. A journey that underscores the country’s role as a strategic base for companies seeking to grow beyond traditional manufacturing and compete in higher value-added segments.
About CINDECINDE is Costa Rica’s expert and strategic guide for investment, business development, and talent initiatives. Thanks to their over 43 years of experience in supporting multinational companies and acting as a key player in the country’s investment ecosystem, CINDE has launched dozens of programs to strengthen local talent as a key element of Costa Rica’s business climate,and has helped establish more than 450 multinational companies in the country.
